| CASE REPORT |
|
| Year : 2010 | Volume
: 42
| Issue : 2 | Page : 110-111 |
Possible cross-sensitivity between sertraline and paroxetine in a panic disorder patient
Praveen H Khairkar, Govind M Bang, Adarshlata B Singh, Prashant G Tiple
Department of Psychiatry and Dermatology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences, (Deemed University), Sawangi (m), Wardha, Maharashtra, India
Correspondence Address:
Praveen H Khairkar
Department of Psychiatry and Dermatology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences, (Deemed University), Sawangi (m), Wardha, Maharashtra
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0253-7613.64497
Cross-sensitivity due to paroxetine and sertraline, the SSRIs, is rarely reported in the literature. We report an adverse drug reaction to paroxetine and sertraline in a patient of panic disorder, who initially developed a maculopapular, erythematous, pruritic rash in the third week with sertraline 50 mg/day. The rash resolved within 2 days of its discontinuation and oral supplementation of diphenhydramine and betamethasone. 10 days following discontinuation of sertraline, the patient was shifted on sustain release paroxetine 12.5 mg/day when another skin reaction with the same appearance and distribution appeared on day 4 of it, suggesting a possibility of cross-sensitivity, a drug class effect. This case report intends to improve the awareness among clinicians to use caution when choosing an alternative SSRIs.
[FULL TEXT] [PDF]*
|
